Literature DB >> 15717287

Increased first-trimester fetal nuchal translucency thickness in association with chondroectodermal dysplasia (Ellis-Van Creveld syndrome).

N Venkat-Raman1, N J Sebire, K W Murphy, J S Carvalho, C M Hall.   

Abstract

Increased nuchal translucency thickness (NT) is an established sonographic marker of fetal chromosomal abnormality. Several structural fetal defects and genetic syndromes including a range of skeletal dysplasias have been reported in association with increased NT. We report the first case of fetal Ellis-Van Creveld syndrome presenting as raised fetal NT at 13 weeks' gestation. Ultrasonography at 18 weeks' gestation demonstrated a narrow thorax, marked shortening of the long bones with bowed femora and hexadactyly of hands and feet. Pregnancy was terminated at 23 weeks' gestation. The postmortem radiological examination revealed short and bowed long bones with rounded metaphyses, postaxial polydactyly of hands and feet, short ribs and narrow thorax. The acetabular roofs were horizontal with medial and lateral spurs. This case adds a further type of severe skeletal dysplasia to the list of genetic syndromes which may present as increased fetal NT in the late first trimester. Copyright 2005 ISUOG

Entities:  

Mesh:

Year:  2005        PMID: 15717287     DOI: 10.1002/uog.1849

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  Ellis-van Creveld syndrome: its history.

Authors:  Oliver J Muensterer; Walter Berdon; Chris McManus; Alan Oestreich; Ralph S Lachman; M Michael Cohen; Stephen Done
Journal:  Pediatr Radiol       Date:  2013-06-12

2.  Ellis-van Creveld syndrome: A rare clinical entity.

Authors:  Reet Kamal; Parveen Dahiya; Simerpreet Kaur; Rohit Bhardwaj; Karun Chaudhary
Journal:  J Oral Maxillofac Pathol       Date:  2013-01

Review 3.  Ellis-van Creveld syndrome.

Authors:  Geneviève Baujat; Martine Le Merrer
Journal:  Orphanet J Rare Dis       Date:  2007-06-04       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.